Crown Laboratories Acquires Aesthetics Eclipse’s Aesthetics Portfolio
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
Skincare company Crown Laboratories has finalized an agreement to acquire the global, aesthetics-focused assets of medical technology company Eclipse.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.